Provided herein are benzenesulfonamide compounds, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
The present application provides, among other things, compounds and methods for metathesis reactions. In some embodiments, provided compounds promote highly efficient and highly Z-selective metathesis. In some embodiments, provided compounds and methods are particularly useful for producing allyl alcohols. In some embodiments, provided compounds have the structure of formula I. In some embodiments, provided compounds comprise ruthenium, and a ligand bonded to ruthenium through a sulfur atom.
[EN] BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF<br/>[FR] DÉRIVÉS DE BENZÈNESULFONAMIDE ET LEURS UTILISATIONS
申请人:2692372 ONTARIO INC
公开号:WO2021009568A1
公开(公告)日:2021-01-21
Provided herein are benzenesulfonamide derivatives having Formula (III), pharmaceutical compositions comprising said compounds, and method for using said compounds for disrupting proteins/polypeptides, protein/polypeptide function, and for the treatment of diseases through the disruption of proteins or polypeptides involved in the etiology of the disease. Said compounds comprise fluorinated benzene sulfonamide structures.
BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF
申请人:2692372 ONTARIO, INC.
公开号:US20240018153A1
公开(公告)日:2024-01-18
Provided herein are benzenesulfonamide compounds, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.